Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia confirms azinphos-methyl approvals

The Australian Pesticides and Veterinary Medicines Authority (APVMA) has formally completed its review of the organophosphate insecticide, azinphos-methyl, and confirmed the continuation of registrations. The APVMA issued its preliminary review for azinphos-methyl in 2006 and published its review findings in 2011 but did not complete the review pending an examination of regulatory decisions in other countries. The APVMA has reviewed those decisions and concluded that there is no new information that would warrant a revision of its 2011 findings. Azinphos-methyl is registered in Australia for use on fruit and nut crops, primarily for the control of codling moths (Cydia pomonella) and light brown apple moths (Epiphyas postvittana). The technical registrant is Adama Australia and the approved end-use products are Adama's Farmoz Gusathion 200 SC and Colin Campbell (Chemicals)'s Campbell Benthion 200 Flowable.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022087

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel